Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
The EMBO Journal
|
August 28, 2003
HS5 of the human beta-globin locus control region: a developmental stage-specific border in erythroid cells
Albert W K Wai, Nynke Gillemans, Selina Raguz-Bolognesi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion
Selina Raguz, Manuela Tamburo De Bella, Gopichani Tripuraneni, et al.
Oncology Reports
|
November 18, 2015
MiR-106b~25 cluster regulates multidrug resistance in an ABC transporter-independent manner via downregulation of EP300
Yunhui Hu, Kaiyong Li, Muhammad Asaduzzaman, et al.
Cancer Research
|
February 7, 2007
Ability to acquire drug resistance arises early during the tumorigenesis process
Ernesto Yagüe, Ana Arance, Loïc Kubitza, et al.
Biochemical Pharmacology
|
November 6, 2012
Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells
Selina Raguz, Caroline Adams, Nahal Masrour, et al.
Molecular Cell
|
June 15, 2010
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a
Kyoko L Yap, Side Li, Ana M Muñoz-Cabello, et al.
Genomics
|
March 21, 2006
The human desmin locus: gene organization and LCR-mediated transcriptional control
Jennifer L Y Tam, Kostas Triantaphyllopoulos, Helen Todd, et al.
International Journal of Cancer
|
October 24, 2007
Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer
Selina Raguz, Rebecca A Randle, Eva R Sharpe, et al.
Breast Cancer Research and Treatment
|
January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Muhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Breast Cancer Research and Treatment
|
March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Muhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
The EMBO Journal
|
August 28, 2003
HS5 of the human beta-globin locus control region: a developmental stage-specific border in erythroid cells
Albert W K Wai, Nynke Gillemans, Selina Raguz-Bolognesi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion
Selina Raguz, Manuela Tamburo De Bella, Gopichani Tripuraneni, et al.
Oncology Reports
|
November 18, 2015
MiR-106b~25 cluster regulates multidrug resistance in an ABC transporter-independent manner via downregulation of EP300
Yunhui Hu, Kaiyong Li, Muhammad Asaduzzaman, et al.
Cancer Research
|
February 7, 2007
Ability to acquire drug resistance arises early during the tumorigenesis process
Ernesto Yagüe, Ana Arance, Loïc Kubitza, et al.
Biochemical Pharmacology
|
November 6, 2012
Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells
Selina Raguz, Caroline Adams, Nahal Masrour, et al.
Molecular Cell
|
June 15, 2010
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a
Kyoko L Yap, Side Li, Ana M Muñoz-Cabello, et al.
Genomics
|
March 21, 2006
The human desmin locus: gene organization and LCR-mediated transcriptional control
Jennifer L Y Tam, Kostas Triantaphyllopoulos, Helen Todd, et al.
International Journal of Cancer
|
October 24, 2007
Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer
Selina Raguz, Rebecca A Randle, Eva R Sharpe, et al.
Breast Cancer Research and Treatment
|
January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Muhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Breast Cancer Research and Treatment
|
March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Muhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Page
of 3